Can an EMT administer a pediatric dose of 1:1000 Epinephrine to a pediatric patient experiencing bronchospasm?

Can an EMT administer a pediatric dose of 1:1000 Epinephrine to a pediatric patient experiencing bronchospasm?

• A. Yes, if patient is in severe distress
• B. Yes, but only with online medical control
• C. No, epinephrine should not be given to pediatric bronchospasm
• D. Yes, if patient is in respiratory arrest or approaching respiratory arrest with criteria

Answer: (D)

The main idea is that epinephrine given as 1:1000 IM is not a routine treatment for pediatric bronchospasm. It is a rescue medication reserved for severe airway compromise when the patient is at the brink of respiratory failure. In EMS practice, this means it should be considered only if the child is in respiratory arrest or showing clear signs that arrest is imminent, and only when the patient meets protocol-defined criteria (and typically with medical control or standing orders). Epinephrine works quickly by both relaxing bronchial smooth muscle (beta-2 effect) and reducing airway edema (alpha-1 effect), which can be life-saving in a deteriorating airway. Because of these strong effects and the potential for adverse reactions like tachycardia or hypertension, its use is restricted to those severe situations rather than all bronchospasm cases. So, the correct approach is to administer epinephrine only when the patient is in respiratory arrest or approaching it with criteria met, rather than for milder distress or without appropriate authorization. In other scenarios, standard treatments such as oxygen and inhaled bronchodilators remain the appropriate first steps.

The main idea is that epinephrine given as 1:1000 IM is not a routine treatment for pediatric bronchospasm. It is a rescue medication reserved for severe airway compromise when the patient is at the brink of respiratory failure. In EMS practice, this means it should be considered only if the child is in respiratory arrest or showing clear signs that arrest is imminent, and only when the patient meets protocol-defined criteria (and typically with medical control or standing orders).

Epinephrine works quickly by both relaxing bronchial smooth muscle (beta-2 effect) and reducing airway edema (alpha-1 effect), which can be life-saving in a deteriorating airway. Because of these strong effects and the potential for adverse reactions like tachycardia or hypertension, its use is restricted to those severe situations rather than all bronchospasm cases.

So, the correct approach is to administer epinephrine only when the patient is in respiratory arrest or approaching it with criteria met, rather than for milder distress or without appropriate authorization. In other scenarios, standard treatments such as oxygen and inhaled bronchodilators remain the appropriate first steps.